Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lymphangiogenesis in cancer: current perspectives.

Identifieur interne : 003831 ( Ncbi/Curation ); précédent : 003830; suivant : 003832

Lymphangiogenesis in cancer: current perspectives.

Auteurs : Rüediger Liersch [Allemagne] ; Christoph Biermann ; Rolf M. Mesters ; Wolfgang E. Berdel

Source :

RBID : pubmed:20033381

Descripteurs français

English descriptors

Abstract

Although the lymphatic system has been initially described in the sixteenth century, basic research has been limited. Despite its importance for the maintenance of tissue fluid homeostasis and for the afferent immune response, research of the molecular mechanisms of lymphatic vessel formation and function has for a long time been hampered. One reason could be because of the difficulties of visibility due to the lack of lymphatic markers. But since the discovery of several molecules specifically expressed in lymphatic endothelial cells, a rediscovery of the lymphatic vasculature has taken place. New scientific insights has facilitated detailed analysis of the nature and organization of the lymphatic system in physiological and pathophysiological conditions, such as in chronic inflammation and metastatic cancer spread. Knowledge about the molecules that control lymphangiogenesis and tumor-associated lymphangiogenesis is now expanding, allowing better opportunities for the development of drugs interfering with the relevant signaling pathways. Advances in our understanding of the mechanisms have translated into a number of novel therapeutic studies.

DOI: 10.1007/978-3-540-78281-0_8
PubMed: 20033381

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:20033381

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Lymphangiogenesis in cancer: current perspectives.</title>
<author>
<name sortKey="Liersch, Ruediger" sort="Liersch, Ruediger" uniqKey="Liersch R" first="Rüediger" last="Liersch">Rüediger Liersch</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, Hematology/Oncology, University Hospital Münster, Albert-Schweitzer-str. 33, 48129, Münster, Germany. rliersch@uni-muenster.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Medicine, Hematology/Oncology, University Hospital Münster, Albert-Schweitzer-str. 33, 48129, Münster</wicri:regionArea>
<wicri:noRegion>48129, Münster</wicri:noRegion>
<wicri:noRegion>48129, Münster</wicri:noRegion>
<wicri:noRegion>Münster</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Biermann, Christoph" sort="Biermann, Christoph" uniqKey="Biermann C" first="Christoph" last="Biermann">Christoph Biermann</name>
</author>
<author>
<name sortKey="Mesters, Rolf M" sort="Mesters, Rolf M" uniqKey="Mesters R" first="Rolf M" last="Mesters">Rolf M. Mesters</name>
</author>
<author>
<name sortKey="Berdel, Wolfgang E" sort="Berdel, Wolfgang E" uniqKey="Berdel W" first="Wolfgang E" last="Berdel">Wolfgang E. Berdel</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20033381</idno>
<idno type="pmid">20033381</idno>
<idno type="doi">10.1007/978-3-540-78281-0_8</idno>
<idno type="wicri:Area/PubMed/Corpus">002C31</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002C31</idno>
<idno type="wicri:Area/PubMed/Curation">002C31</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002C31</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002C31</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002C31</idno>
<idno type="wicri:Area/Ncbi/Merge">003831</idno>
<idno type="wicri:Area/Ncbi/Curation">003831</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Lymphangiogenesis in cancer: current perspectives.</title>
<author>
<name sortKey="Liersch, Ruediger" sort="Liersch, Ruediger" uniqKey="Liersch R" first="Rüediger" last="Liersch">Rüediger Liersch</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, Hematology/Oncology, University Hospital Münster, Albert-Schweitzer-str. 33, 48129, Münster, Germany. rliersch@uni-muenster.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Medicine, Hematology/Oncology, University Hospital Münster, Albert-Schweitzer-str. 33, 48129, Münster</wicri:regionArea>
<wicri:noRegion>48129, Münster</wicri:noRegion>
<wicri:noRegion>48129, Münster</wicri:noRegion>
<wicri:noRegion>Münster</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Biermann, Christoph" sort="Biermann, Christoph" uniqKey="Biermann C" first="Christoph" last="Biermann">Christoph Biermann</name>
</author>
<author>
<name sortKey="Mesters, Rolf M" sort="Mesters, Rolf M" uniqKey="Mesters R" first="Rolf M" last="Mesters">Rolf M. Mesters</name>
</author>
<author>
<name sortKey="Berdel, Wolfgang E" sort="Berdel, Wolfgang E" uniqKey="Berdel W" first="Wolfgang E" last="Berdel">Wolfgang E. Berdel</name>
</author>
</analytic>
<series>
<title level="j">Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer</title>
<idno type="ISSN">0080-0015</idno>
<imprint>
<date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Endothelial Cells (physiology)</term>
<term>Humans</term>
<term>Lymphangiogenesis</term>
<term>Lymphatic Metastasis</term>
<term>Lymphatic System (embryology)</term>
<term>Lymphatic System (physiology)</term>
<term>Lymphedema (etiology)</term>
<term>Neoplasm Invasiveness</term>
<term>Neoplasms (etiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Cellules endothéliales (physiologie)</term>
<term>Humains</term>
<term>Invasion tumorale</term>
<term>Lymphangiogenèse</term>
<term>Lymphoedème (étiologie)</term>
<term>Métastase lymphatique</term>
<term>Système lymphatique (embryologie)</term>
<term>Système lymphatique (physiologie)</term>
<term>Tumeurs (étiologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="embryologie" xml:lang="fr">
<term>Système lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="embryology" xml:lang="en">
<term>Lymphatic System</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Lymphedema</term>
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Cellules endothéliales</term>
<term>Système lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Endothelial Cells</term>
<term>Lymphatic System</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Lymphoedème</term>
<term>Tumeurs</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Humans</term>
<term>Lymphangiogenesis</term>
<term>Lymphatic Metastasis</term>
<term>Neoplasm Invasiveness</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Humains</term>
<term>Invasion tumorale</term>
<term>Lymphangiogenèse</term>
<term>Métastase lymphatique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Although the lymphatic system has been initially described in the sixteenth century, basic research has been limited. Despite its importance for the maintenance of tissue fluid homeostasis and for the afferent immune response, research of the molecular mechanisms of lymphatic vessel formation and function has for a long time been hampered. One reason could be because of the difficulties of visibility due to the lack of lymphatic markers. But since the discovery of several molecules specifically expressed in lymphatic endothelial cells, a rediscovery of the lymphatic vasculature has taken place. New scientific insights has facilitated detailed analysis of the nature and organization of the lymphatic system in physiological and pathophysiological conditions, such as in chronic inflammation and metastatic cancer spread. Knowledge about the molecules that control lymphangiogenesis and tumor-associated lymphangiogenesis is now expanding, allowing better opportunities for the development of drugs interfering with the relevant signaling pathways. Advances in our understanding of the mechanisms have translated into a number of novel therapeutic studies.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003831 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 003831 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:20033381
   |texte=   Lymphangiogenesis in cancer: current perspectives.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:20033381" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024